0001209191-17-041644.txt : 20170623
0001209191-17-041644.hdr.sgml : 20170623
20170623162243
ACCESSION NUMBER: 0001209191-17-041644
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170622
FILED AS OF DATE: 20170623
DATE AS OF CHANGE: 20170623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Deeg Mark Albert
CENTRAL INDEX KEY: 0001708820
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 17927825
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-22
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001708820
Deeg Mark Albert
C/O REGULUS THERAPEUTICS
10614 SCIENCE CENTER DR.
SAN DIEGO
CA
92121
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
0.99
2017-06-22
4
A
0
100000
0.00
A
2017-06-21
Common Stock
100000
100000
D
25% of the shares vest on June 22, 2018 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on June 22, 2021.
Christopher Aker, Attorney in Fact
2017-06-23